Vericel (VCEL) Interest & Investment Income (2010 - 2026)
Vericel's (VCEL) quarterly Interest & Investment Income came in at $1.9 million in Q1 2026, up 11.71% year-on-year from $1.7 million in Q1 2025, and down 1.8% quarter-over-quarter from $1.9 million in Q4 2025.
Vericel (VCEL) Interest & Investment Income (2010 - 2026) Analysis & Trends
Vericel has disclosed Interest & Investment Income across 17 years of filings, most recently posting $1.9 million for Q1 2026.
- Interest & Investment Income for Q1 2026 came in at $1.9 million, up 11.71% year-over-year; the trailing twelve-month figure through Mar 2026 was $7.2 million (up 14.21% YoY), and the FY2025 annual result was $7.0 million, up 9.31% from the prior year.
- Interest & Investment Income came in at $1.9 million for Q1 2026 at Vericel, down from $1.9 million in the prior quarter.
- In the past five years, Interest & Investment Income ranged from a high of $1.9 million in Q4 2025 to a low of $88000.0 in Q1 2022.
- The 5-year median for Interest & Investment Income is $1.5 million (2024), against an average of $1.2 million.
- Across the five-year window, Interest & Investment Income surged 1150.82% in 2022 and dropped 5.96% in 2025, its largest moves.
- Vericel's Interest & Investment Income stood at $763000.0 in 2022, then surged by 88.2% to $1.4 million in 2023, then increased by 8.64% to $1.6 million in 2024, then climbed by 20.83% to $1.9 million in 2025, then retreated by 1.8% to $1.9 million in 2026.
- The last three Interest & Investment Income figures came in at $1.9 million (Q1 2026), $1.9 million (Q4 2025), and $1.8 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 597,319.59 |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 40.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 305,000.00 |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 103,341.00 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 114.80 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -14.79 Mn |
| 10 | Vericel | 2.04 Bn | 1.90 Bn | 49.27 Mn | 1.85 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.85 Mn |
| Dec 31, 2025 | 1.89 Mn |
| Sep 30, 2025 | 1.81 Mn |
| Jun 30, 2025 | 1.66 Mn |
| Mar 31, 2025 | 1.66 Mn |
| Dec 31, 2024 | 1.56 Mn |
| Sep 30, 2024 | 1.58 Mn |
| Jun 30, 2024 | 1.51 Mn |
| Mar 31, 2024 | 1.76 Mn |
| Dec 31, 2023 | 1.44 Mn |
| Sep 30, 2023 | 1.26 Mn |
| Jun 30, 2023 | 1.10 Mn |
| Mar 31, 2023 | 839,000.00 |
| Dec 31, 2022 | 763,000.00 |
| Sep 30, 2022 | 342,000.00 |
| Jun 30, 2022 | 148,000.00 |
| Mar 31, 2022 | 88,000.00 |
| Dec 31, 2021 | 61,000.00 |
| Sep 30, 2021 | 44,000.00 |
| Jun 30, 2021 | 43,000.00 |